Topics
Latest
AI
Amazon
Image Credits:Levy Health
Apps
Biotech & Health
mood
Image Credits:Levy Health
Cloud Computing
commercialism
Crypto
Enterprise
EVs
Fintech
Fundraising
gizmo
back
Government & Policy
ironware
layoff
Media & Entertainment
Meta
Microsoft
Privacy
Robotics
surety
societal
distance
Startups
TikTok
Transportation
Venture
More from TechCrunch
Events
Startup Battlefield
StrictlyVC
newssheet
Podcasts
picture
Partner Content
TechCrunch Brand Studio
Crunchboard
adjoin Us
Caroline Mitterdorfer ’s fertility journeying began with an early - phase cancer diagnosis at age 27 . She told TechCrunch that her diagnosing made her realize how little she knew about her wellness and her fertility . She dove into research the space and became a self - delineate fertility advocate .
Through that work , Mitterdorfer notice that it take on a long time for doctors to name prolificacy issues . She co - founded Levy Health to help speed up the process .
San Francisco - base Levy Health built a clinical decision support chopine to help physicians and fertility medical specialist diagnose women with fertility issues earlier . The political program has users fill out a whole host of questions , like how long they ’ve been trying to get significant and whether they track ovulation , and it has them submit necessary research lab study before an appointment with a fertility rate medical specialist .
Levy Health ’s software analyzes a patient role ’s questionnaire , biomarkers , and labs and narrow down down a listing of 110 potential diagnoses to a few potential conditions a patient might have . It presents this information , and possible treatment option , to doctor before they see their patient role . While physicians survey everything before it is presented to patient role , Mitterdorfer say that this process has lead to a 50 % step-down in clock time to diagnosing .
Mitterdorfer say that while clinical determination support platforms are n’t young , they are to the fertility space . Part of the reason it can take so long for charwoman to get diagnosed is that they are peach about fertility rate issues with their OB - GYN or basal care provider , who are n’t necessarily equipped with the proper knowledge on endocrine disorder like infertility , she said .
“ We really think we can alter how fair sex get accession to an early diagnosing by authorise the diagnoser , ” Mitterdorfer said . “ natality clinics , they have a Brobdingnagian trouble : There is more demand than supplying , and a muckle of innovation is in the IVF lab , not as much in funneling patients through . ”
Through her fertility advocacy , Mitterdorfer met her carbon monoxide gas - founders Silvia Hecher , CPO , who ’s moderate numerous persona in birthrate clinic and companies , and Dr. Theresa Vilsmaier , ground physician focalise on gynecology .
Join us at TechCrunch Sessions: AI
Exhibit at TechCrunch Sessions: AI
The trio launch the company in 2022 in Germany . Despite get regulatory approval in Europe , Mitterdorfer said that they speedily recognize that the European market place was n’t align with the company because Levy Health did n’t want to pass any of the costs on to consumers . So the company packed up and moved to the U.S. where it is based now .
Levy Health launched in the U.S. in 2023 . The ship’s company has landed six B2B customer , including Progyny , a fertility benefits company ; Boston IVF , a chain of fertility clinic ; and Everie , an egg donation organization .
“ The self-aggrandising challenge of a company in a healthcare space is find the first five customers , ” Mitterdorfer say . “ Good Book of mouth in health care is significant . One of our first companies being Progyny helps build that trust and substantiation . ”
Levy Health just raised a $ 4.5 million seed round extend by XYZ Venture Capital with participation from Atlantic Labs and Possible Ventures . Mitterdorfer said that the company will use the stock to continue building the team and technology but also to help fund clinical study related to area like fertility and ballock freezing .
“ We are focusing on publishing a clinical study over the next six months for clinical reinforcement for woman to immobilise their eggs , validating our KPIs , ” Mitterdorfer said . “ It ’s a spate about combine , also a lot of , ‘ Do you really leave the value proposition that you are trying to deliver ? ’ ”
Fertility health as a market has continued to attain momentum . The U.S. fertility market was valued at $ 6.19 billion in 2023 , according toPrecedence Research , and is have a bun in the oven to grow 63 % by 2033 .
There are legion caller approach the trouble from various angles . Carrotis a fertility - focused employee welfare supplier that has raised $ 114 million in venture majuscule . Mirais an at - nursing home hormone examination outfit that has stir $ 4.3 million in VC.Pozitivfis a chain of fertility clinics that has bring up $ 20 million .
“ For me , it is just critical to get it on that what we are building is helping , at the death of the day , hopefully millions of womanhood getting an other diagnosing , ” Mitterdorfer enounce .
